(2)Commission Implementing Regulation (EU) 2021/745note extended the approval period of the active substance heptamaloxyloglucan until 31 May 2022.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.
law://eu/reg/2022/814/rct_2@2026-11-11Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.